Treatment | Concentration | Anti-inflammatory activities (% Inhibition) | |||
---|---|---|---|---|---|
COX1 | COX2 | 15-LOX | sPLA2 | ||
Control | – | 45.26 ± 2.31b | 33.40 ± 1.02ab | 51.46 ± 3.19b | 55.95 ± 2.09b |
Yeast extract (mg/L) | 1 | 43.01 ± 1.05b | 31.74 ± 3.76b | 48.90 ± 2.42b | 53.17 ± 1.87b |
10 | 37.91 ± 4.01bc | 27.98 ± 1.43bc | 43.10 ± 1.13bc | 46.87 ± 2.61c | |
50 | 44.76 ± 2.24b | 33.03 ± 1.27ab | 50.88 ± 0.88b | 55.32 ± 3.13b | |
100 | 52.20 ± 1.31a | 38.52 ± 0.79a | 59.35 ± 1.13a | 64.53 ± 2.25a | |
200 | 37.60 ± 3.56bc | 27.75 ± 3.14bc | 42.75 ± 3.02bc | 46.48 ± 1.13c | |
Pectin (mg/L) | 1 | 27.05 ± 0.72cd | 19.96 ± 2.61 | 30.75 ± 2.65d | 33.44 ± 2.25de |
10 | 30.59 ± 1.38c | 22.57 ± 2.44c | 34.78 ± 3.63cd | 37.82 ± 3.41d | |
50 | 26.27 ± 0.94cd | 19.39 ± 1.83d | 29.87 ± 1.22d | 32.48 ± 2.72de | |
100 | 42.44 ± 1.61b | 31.32 ± 1.68b | 48.25 ± 1.63b | 52.46 ± 1.37bc | |
250 | 40.46 ± 1.44bc | 29.85 ± 0.95b | 45.99 ± 2.24bc | 50.01 ± 2.01bc | |
500 | 33.33 ± 1.75c | 24.60 ± 1.28bc | 37.90 ± 1.96c | 41.21 ± 0.99cd |